1/1
WOMANPOWER study
online resource
posted on 2022-03-30, 15:17 authored by Kirsty Le DoareKirsty Le Doare, Eve NakabembeDocuments from clinical trial:
The safety and imMunogeNicity of combined Pertussis-cOntaining vaccine (Tdap) for HIV-infected pregnant WomEn and their newboRns (WoMANPOWER)
Funding
Medical Research Council Joint Clinical Trials Scheme Round 9
Wellcome Trust 104482- ‘Group-B streptococci: developing a correlate of protection for future vaccine trials with the help of pregnant Gambian women and their infants
History
Research Institute
- Infection and Immunity
